0
$0.00
A clear glass vial with a gold cap labeled “Semaglutide 5mg/1mL” in green text, containing colorless liquid, sits on a white background.
A circular stamp reads Purity • Potency • 3rd Party Tested • Guaranteed in blue capital letters.

BATCH

PURITY

99% HPLC

  • CAS #:
  • 910463-68-2
  • Formula:
  • C187H291N45O59
  • M.W.:
  • 4113.58 g/mol

GLP-1 (S)

Appetite ReshapingGlucose RegulationMetabolic EfficiencyWeight Loss

Price range: $95.00 through $462.00

Volume Pricing Guide

QUANTITY PRICE PER
1 $95.00
2 - 4 $85.50
5 - 9 $80.75
10 - 14 $76.00
15 - 19 $71.25
20 + $66.50

Only the lyophilized product is provided. For research use only. All supplies sold separately.  

Section divider line

Summary

​​Semaglutide is a synthetic analogue of the naturally occurring glucagon-like peptide-1 (GLP-1), which plays a critical role in regulating glucose metabolism, appetite, and energy balance1,2. As the active ingredient in groundbreaking therapies like Ozempic, Wegovy, and others, Semaglutide has transformed the treatment landscape for diabetes and obesity. In clinical trials, individuals receiving Semaglutide achieved weight loss of up to 15% of total body weight over 68 weeks when combined with lifestyle interventions2,3. Its mechanisms extend beyond glucose control, offering cardiovascular and neuroprotective benefits, as well as appetite regulation for both food and alcohol. By optimizing metabolic and systemic functions, Semaglutide supports patients in taking the most challenging yet crucial first step toward reclaiming their health and vitality.

Research Recommendations

  • Protocol: 5 units weekly, increase as needed.
  • Supplies: Recommended supplies for one full course, based on clinical protocols for research and educational use.
  • Peptide Vials
  • 1
  • Bags of Needles
  • 1
  • Alcohol pad Bundles
  • 1
  • Bacteriostatic Water
  • 1
Section divider line

Batch Testing Reports

GLP-1

Certificate of Analysis for Semaglutide from Simon’s Compounding, featuring batch details, sample info, assay and purity results, chromatogram graph, plus company branding and contact information.
Section divider line

Description & Pharmacodynamics

Mechanisms of Action

  1. Glucose Regulation: Enhances insulin secretion in a glucose-dependent manner while suppressing glucagon release, reducing hepatic glucose production, and stabilizing blood sugar levels (1, 3).
  2. Appetite Suppression and Weight Loss: By activating GLP-1 receptors in the hypothalamus and brainstem, GLP-1 (S) increases satiety, slows gastric emptying, and reduces caloric intake (2, 3).
  3. Beta Cell Protection: Promotes pancrAOD-9604, 5 mg
    BPC157, 10 mg
    BPC157, 20 mg
    BPC157 TB500, Wolverine, 10 mg and 10 mg
    GHK BPC157 TB500, Glow, 50 mg, 10 mg, 10 mg
    GHK KPV BPC157 TB500, Klow, 25 mg, 10 mg, 10 mg, 10 mg
    Cerebrolysin, 1200 mg
    CJC no DAC, 10 mg
    CJC with DAC, 10 mg
    CJC Ipamorelin, 5 mg and 5 mg
    Epitalon, 10 mg
    GHK-Cu, 50 mg
    Glutathione, 1500 mg
    Ipamorelin, 10 mg
    Kisspeptin, 10 mg
    KPV, 10 mg
    LL37, 4 mg
    Melanotan 1, 10 mg
    Melanotan 2, 10 mg
    MOTS-c, 10 mg
    NAD, 1000 mg
    Pinealon, 20 mg
    PT141, 10 mg
    Selank, 10 mg
    Semax, 30 mg
    Sermorelin, 10 mg
    TA-1, 10 mg
    TB500, 10 mg
    Tesamorelin, 20 mg
    Tesa Ipa 2x, 10 mg and 5 mg
    GLP-1R, 12 mg, 24 mg, 50 mg
    GLP-1S, 12.5 mg, 20 mg, 50 mg
    GLP-1T, 10 mg, 30 mg, 60 mg, 90 mg
    eatic beta cell growth, proliferation, and protection from apoptosis, supporting insulin production and pancreatic health (    4).
  4. Cardiovascular Benefits: Reduces left ventricular end-diastolic pressure, improves glucose uptake in ischemic heart tissue, and lowers systemic vascular resistance, enhancing cardiac function (4, 5).
  5. Neuroprotective Properties: Mitigates amyloid-beta plaque formation, promotes neuron survival, and supports cognitive function through interactions with brain GLP-1 receptors (6).

Pharmacokinetics
GLP-1 (S) has a long half-life (~165 hours), allowing for once-weekly dosing. This extended duration improves adherence and maintains consistent therapeutic effects (1, 3).

Section divider line

Research Insights

Weight Loss and Obesity Management
  • Clinical studies show that individuals treated with GLP-1 (S) experienced weight reductions of up to 15% over 68 weeks, significantly outperforming placebo groups (2, 3).
  • Enhanced satiety and reduced caloric intake were key drivers of this outcome (2, 3).
Diabetes and Glycemic Control
  • Reduces HbA1c levels by up to 1.5% in Type 2 diabetes, minimizing the risk of long-term complications (1, 3).
  • Improves fasting and postprandial glucose control while preserving beta-cell function (4).
Cardiovascular Health
  • Demonstrated reduction in cardiovascular events in patients with diabetes and obesity (5).
  • Enhances myocardial glucose uptake and reduces ventricular pressure, aiding heart function (4, 5).
Neuroprotective Potential
  • Animal studies indicate that GLP-1 (S) slows amyloid-beta accumulation, enhances spatial memory, and supports neuron survival (6).
  • Emerging research suggests it could delay Alzheimer’s progression, though further studies are needed (6).
Section divider line

Structure

  • Sequence: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Thr-Lys-Lys-Ser-Lys-Gln-Gly-Glu-Leu-Ala-Gln-Gly-Glu-Arg-Arg-Gln-Glu-Lys-Ala-Glu-Arg-Arg-Ser-Asp-Gly-Thr-Phe-Thr-Asn-Ser.
  • Molecular Formula: C187H291N45O59
  • Molecular Weight: 4113.64 g/mol
  • PubChem CID: 11966638
A structural diagram of semaglutide, a peptide medication, highlighting its long amino acid chain with specific chemical modifications and side groups attached along the backbone.
Section divider line

Citations for GLP-1 (S)

Metabolic and Glycemic Regulation
  1. Holst, J. J. From the Incretin Concept and the Discovery of GLP-1 to Today’s Diabetes Therapy. Front Endocrinol, 2019.
  2. Drucker, D. J. Mechanisms of Action and Therapeutic Applications of GLP-1. Cell Metab, 2018.
Weight Loss and Appetite Regulation
  1. Wilding, J. P. H., et al. Once-weekly Semaglutide in Adults with Overweight or Obesity. New Engl J Med, 2021.
Cardiovascular Health
  1. Marso, S. P., et al. Cardiovascular Outcomes in Patients with Type 2 Diabetes on Semaglutide. New Engl J Med, 2016.
  2. Drucker, D. J., et al. GLP-1 Receptor Agonists and Cardiovascular Risk Reduction. Diabetes Care, 2020.
Neuroprotective Research
  1. “GLP-1 (S) and Neurodegenerative Disease,” Diabetes Care Journal, 2020.

**Note:** This product is intended for research purposes only and not for human consumption. Always consult with a healthcare professional before starting any new supplement or research product.

Researched Pairings

AOD-9604

Fat Burner

A clear glass vial labeled AOD-9604 with a gold cap (2mg/1ml) stands upright on a plain background.

$88.00

View
Buy This product has multiple variants. The options may be chosen on the product page

Lean Muscle Mass Peptide Stack

The Lean Muscle Mass Peptide Stack includes three clear glass vials with gold caps labeled TB-500, C1295 + Ipamorelin, and IGF-1 LR3, each featuring dosage info and a green symbol on white labels.

$805.00

View
Buy

GLP-1 (S) + Cagrilintide

2ND GENERATION "OZEMPIC"

A small clear glass vial with a gold cap, labeled Semaglutide / Cagrilintide 5mg in green font, rests on a plain white background.

Price range: $115.00 through $220.00

View
Buy This product has multiple variants. The options may be chosen on the product page

GLP-2 (T)

"GLP-2" PEPTIDE

A small glass vial with a gold cap labeled Tirzepatide 10 mg in black text, containing a white powder, on a plain background.

Price range: $250.00 through $850.00

View
Buy This product has multiple variants. The options may be chosen on the product page